Literature DB >> 21309928

Low plasma antibodies specific for phosphatidylethanol in alcohol abusers and patients with alcoholic pancreatitis.

Antti E Nissinen1, L Maria Laitinen, Sakari Kakko, Anders Helander, Markku J Savolainen, Sohvi Hörkkö.   

Abstract

Phosphatidylethanol (PEth) is a group of alcohol-modified phospholipids present in cell membranes after heavy drinking. Our aim was to demonstrate the presence of human plasma antibodies binding to PEth and to address their specificity and value in detecting subjects engaged in heavy alcohol consumption. Antibodies to PEth were analyzed in plasma from heavy drinkers (n=20), patients with alcoholic pancreatitis (n=58) and control subjects (n=24), using chemiluminescent immunoassay. Heavy drinkers and patients with alcoholic pancreatitis demonstrated significantly lower levels of plasma IgG, IgA and IgM titers to PEth compared with controls (P<0.001). The specificity of the antibodies to PEth was demonstrated with competitive liquid phase immunoassays and flow cytometry. The plasma IgG, but not IgA or IgM, titers to PEth in heavy drinkers correlated with the whole blood PEth concentration determined by liquid chromatography-mass spectrometry (r=0.655, P=0.002). Compared with traditional markers for alcohol abuse (aspartate aminotransferase, gamma-glutamyl transpeptidase and mean corpuscular volume), receiver operating characteristic curve analysis showed that a low plasma IgA to PEth had the highest area under the curve (AUC 0.940, P<0.001). In conclusion, plasma IgG, IgA and IgM antibodies binding specifically to PEth were found in subjects of all study groups. Subjects with heavy alcohol consumption showed markedly lower plasma immunoglobulin levels to PEth, potentially making them useful as a biomarker to distinguish heavy from moderate alcohol use.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309928     DOI: 10.1111/j.1369-1600.2010.00279.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  3 in total

1.  Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.

Authors:  Michael G McDonell; Jordan Skalisky; Emily Leickly; Michael F Orr; Sterling McPherson; John Roll; Nathalie Hill-Kapturczak; Martin Javors
Journal:  Psychol Addict Behav       Date:  2017-07-17

2.  Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa.

Authors:  Judith A Hahn; Loren M Dobkin; Bernard Mayanja; Nneka I Emenyonu; Isaac M Kigozi; Stephen Shiboski; David R Bangsberg; Heike Gnann; Wolfgang Weinmann; Friedrich M Wurst
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

Review 3.  Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis.

Authors:  Guido Viel; Rafael Boscolo-Berto; Giovanni Cecchetto; Paolo Fais; Alessandro Nalesso; Santo Davide Ferrara
Journal:  Int J Mol Sci       Date:  2012-11-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.